acetylglucosamine has been researched along with Sarcoma 180 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, C; Kong, X; Liang, Y; Liu, W; Rong, M; Xu, W | 1 |
| Bogdanov, IG; Dalev, PG; Gurevich, AI; Kolosov, MN; Malékova, VP; Plemyannikova, LA; Sorokina, IB | 1 |
| Abe, S; Kifune, K; Koto, T; Nakamura, T; Nakamura, Y; Suzuki, K; Tachibana, M; Tsurutani, R; Yoshimura, H; Yoshimura, M | 1 |
3 other study(ies) available for acetylglucosamine and Sarcoma 180
| Article | Year |
|---|---|
Chitooligosaccharides and N-acetyl-D-glucosamine stimulate peripheral blood mononuclear cell-mediated antitumor immune responses.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Immunologic; Flow Cytometry; Gene Expression Regulation, Neoplastic; Immunity, Cellular; Immunohistochemistry; Interferon-gamma; Interleukin-2; Leukocytes, Mononuclear; Mice; Oligosaccharides; Organ Size; Sarcoma 180; Spleen; Thymus Gland; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Antitumour glycopeptides from Lactobacillus bulgaricus cell wall.
Topics: Acetylglucosamine; Amino Acids; Animals; Antineoplastic Agents; Bacterial Proteins; Cell Wall; Glycopeptides; Glycoproteins; Lactobacillus; Mice; Molecular Weight; Muramic Acids; Sarcoma 180 | 1975 |
[Development of slow releasing anticancer drug based with absorbable biomaterial chitin].
Topics: Absorption; Acetylglucosamine; Animals; Chitin; Cisplatin; Delayed-Action Preparations; Mice; Platinum; Rabbits; Sarcoma 180 | 1991 |